291 related articles for article (PubMed ID: 8917700)
21. Pharmacokinetics of the toxic fraction of Centruroides limpidus limpidus venom in experimentally envenomed rabbits and effects of immunotherapy with specific F(ab')2.
Calderón-Aranda ES; Rivière G; Choumet V; Possani LD; Bon C
Toxicon; 1999 May; 37(5):771-82. PubMed ID: 10219988
[TBL] [Abstract][Full Text] [Related]
22. Intravenous
Kurtović T; Karabuva S; Grenc D; Dobaja Borak M; Križaj I; Lukšić B; Halassy B; Brvar M
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919927
[No Abstract] [Full Text] [Related]
23. Inhibition of the myotoxic activities of three African Bitis venoms (B. rhinoceros, B. arietans and B. nasicornis) by a polyvalent antivenom.
Ponte CG; Nóbrega EL; Fernandes VC; da Silva WD; Suarez-Kurtz G
Toxicon; 2010; 55(2-3):536-40. PubMed ID: 19857507
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
Audebert F; Urtizberea M; Sabouraud A; Scherrmann JM; Bon C
J Pharmacol Exp Ther; 1994 Mar; 268(3):1512-7. PubMed ID: 8138962
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evolution and circulating venom levels in scorpion envenomations in Morocco].
el Hafny B; Ghalim N
Bull Soc Pathol Exot; 2002 Aug; 95(3):200-4. PubMed ID: 12404872
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma.
Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203
[TBL] [Abstract][Full Text] [Related]
28. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the microcirculation and the state of oxidative stress in the rat after scorpion envenomation.
Sahnoun Z; Chaker-Krichen S; Kassis M; Hakim A; Hammami S; Ghozzi H; Bouayed N; Bellasfar Z; Zeghal KM; Rebai T
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):263-8. PubMed ID: 17324135
[TBL] [Abstract][Full Text] [Related]
30. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
[TBL] [Abstract][Full Text] [Related]
31. The Effect of a Polyvalent Antivenom on the Serum Venom Antigen Levels of Naja sputatrix (Javan Spitting Cobra) Venom in Experimentally Envenomed Rabbits.
Yap MK; Tan NH; Sim SM; Fung SY; Tan CH
Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):274-9. PubMed ID: 25819552
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
Abd El-Aty AM; Goudah A; Abo El Sooud K
Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration.
Goudah A; Abo El-Sooud K; Shim JH; Shin HC; Abd El-Aty AM
J Vet Pharmacol Ther; 2008 Oct; 31(5):399-405. PubMed ID: 19000258
[TBL] [Abstract][Full Text] [Related]
35. [Application of ELISA for the quantification of Androctonus australis hector venom in the envenomed serum of people and rats before and after immunotherapy].
Hammoudi-Triki D; Laraba-Djebari F
Bull Soc Pathol Exot; 2003 Nov; 96(4):297-301. PubMed ID: 14717046
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the neurotoxic and myotoxic effects of two Moroccan scorpion venoms and their neutralization by experimental polyclonal antivenom.
Oukkache N; Ahmad Rusmili MR; Othman I; Ghalim N; Chgoury F; Boussadda L; Elmdaghri N; Sabatier JM
Life Sci; 2015 Mar; 124():1-7. PubMed ID: 25623852
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses.
Magdesian KG; Hogan PM; Cohen ND; Brumbaugh GW; Bernard WV
J Am Vet Med Assoc; 1998 Oct; 213(7):1007-11. PubMed ID: 9776999
[TBL] [Abstract][Full Text] [Related]
39. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
40. Immunoreactivity of a new generation of horse F(ab')2 preparations against European viper venoms and the tetanus toxin.
Pépin-Covatta S; Lutsch C; Grandgeorge M; Scherrmann JM
Toxicon; 1997 Mar; 35(3):411-22. PubMed ID: 9080596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
